Clinical Diagnostics Market: By Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Other Tests), By Product (Instruments, Reagents, and Data Management Systems), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, and Other End Users) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Clinical Diagnostics Market size was valued at USD 50.11 billion in 2022, growing at a significant CAGR of 5.02% over 2023-2029. Some of the key factors influencing the market growth include growth in patients with long-term diseases/ disorders like diabetes, cardiovascular diseases, hypertension, etc. where frequent testing is required. Also increase in the geriatric population plays a key role in the market. Expansion and advancements of these diagnostic tests are also thriving the market growth. An increase in health expenditure, rising in awareness about health care, and testing in people are the important factors of the market growth. However, the high requirement of initial capital amount, stringent regulations by the government, complex operating procedure of equipment, and lack of skilled professionals are somehow restraining the market in some regions.  Clinical diagnostics is the process of identifying a disease by signs, symptoms, a patient's medical history, and a physical examination. They include the production, development, and marketing of test kits, automated test systems, and informatics systems. They aid in disease management to enhance patients' overall health and well-being. They also assist in the classification of patients with various diseases so that focused medication can be given to them. Additionally, they can enhance the effectiveness of medicines, forecast therapeutic efficacy, and protect patients from long-term problems. As a result, clinical diagnostics are widely used in point-of-care testing, diagnostic laboratories, and hospital laboratories all over the world.

Clinical Diagnostics Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Clinical Diagnostics Market Dynamics

The development of complex and specialised tests for early illness diagnosis and disease management, as well as rising demand for lab automation, are expected to fuel expansion in the worldwide clinical diagnostics market throughout the forecast period. The growing use of point-of-care diagnostics has ushered in a trend of decentralisation in the healthcare business.

Clinical Diagnostics Market Segmentation

By Test Type
  • Lipid Panel
  • Metabolic Panel
  • Liver Panel
  • Renal Panel
  • Complete Blood Count
  • Electrolyte Testing
  • Infectious Disease Testing
  • Other Tests
By Product
  • Instruments
  • Reagents
  • Data Management Systems
By End User
  • Hospital
  • Diagnostic Laboratory
  • Point-of-Care Testing
  • Other End Users

Frequently Asked Questions

The clinical diagnostics market key players are: Abbott Laboratories, ARUP Laboratories, Becton, Dickinson and Company, Bioscientia Healthcare, Bio-Rad Laboratories Inc., Bio-Reference Laboratories, BioMerieux, Charles River Laboratories, Clarient Inc., Danaher Corporation, Diasorin, Genoptix Medical Laboratory, Genzyme Corporation, Healthscope Limited., Hologic Inc, Labco S.A., Laboratory Corporation of America Holdings (Labcorp), Ortho Clinical Diagnostics, Qiagen, Quest Diagnostics Inc., Roche Diagnostics, Siemens AG Healthcare, Sonic Healthcare Ltd, Thermo Fisher Scientific

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market, and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup's details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Abbott Laboratories
  • ARUP Laboratories
  • Bioscientia Healthcare
  • Bio-Rad Laboratories Inc.
  • Bio-Reference Laboratories
  • BioMerieux
  • Charles River Laboratories
  • Clarient Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Diasorin
  • Genoptix Medical Laboratory
  • Genzyme Corporation
  • Healthscope Limited.
  • Hologic Inc
  • Labco S.A.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Ortho Clinical Diagnostics
  • Qiagen
  • Quest Diagnostics Inc.
  • Roche Diagnostics
  • Siemens AG Healthcare
  • Sonic Healthcare Ltd
  • Thermo Fisher Scientific

Adjacent Markets